Precision Biosciences Stock Analysis

Precision Stock Analysis Notes

About 45.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Precision BioSciences had not issued any dividends in recent years. The entity had 1:30 split on the 14th of February 2024. Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Precision Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 192 people. To learn more about Precision BioSciences call Michael Amoroso at 919 314 5512 or check out https://www.precisionbiosciences.com.

Precision BioSciences Investment Alerts

Precision BioSciences Upcoming and Recent Events

Precision Largest EPS Surprises

View All Earnings Estimates

Precision BioSciences Environmental, Social, and Governance (ESG) Scores

Precision BioSciences Thematic Classifications

Precision Stock Institutional Investors

Note, although Precision BioSciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Precision Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.08 M.

Precision Profitablity

The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (36.94) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $36.94.

Management Efficiency

Precision BioSciences has return on total asset (ROA) of (0.0638) % which means that it has lost $0.0638 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2444 %, meaning that it created $0.2444 on every $100 dollars invested by stockholders. Precision BioSciences' management efficiency ratios could be used to measure how well Precision BioSciences manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.4. The value of Return On Capital Employed is expected to slide to -0.42. At this time, Precision BioSciences' Fixed Asset Turnover is quite stable compared to the past year. Asset Turnover is expected to rise to 0.32 this year, although the value of Other Assets will most likely fall to 0.95.

Technical Drivers

As of the 22nd of November, Precision BioSciences holds the Coefficient Of Variation of (1,101), variance of 9.01, and Risk Adjusted Performance of (0.06). Precision BioSciences technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Precision BioSciences market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Precision BioSciences is priced some-what accurately, providing market reflects its current price of 6.5 per share. Given that Precision BioSciences has information ratio of (0.12), we recommend you to check out Precision BioSciences's recent market performance to make sure the company can sustain itself at a future point.

Precision BioSciences Price Movement Analysis

Precision BioSciences Insider Trading Activities

Precision BioSciences Outstanding Bonds

Precision BioSciences Predictive Daily Indicators

Precision BioSciences Corporate Filings

Precision BioSciences Forecast Models

Precision BioSciences' time-series forecasting models are one of many Precision BioSciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Precision BioSciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Precision BioSciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Precision shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Precision BioSciences. By using and applying Precision Stock analysis, traders can create a robust methodology for identifying Precision entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Precision analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Precision analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Precision BioSciences stock analysis indicators help investors evaluate how Precision BioSciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Precision BioSciences shares will generate the highest return on investment. By understating and applying Precision BioSciences stock analysis, traders can identify Precision BioSciences position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.